Nasopharyngeal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma Interventions: Drug: Sintilimab, bevacizumab, gemcitabine; Radiation: IMRT Sponsors: Zhejiang Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials

Artificial Intelligence-supported Reading Versus Standard Double Reading for the Interpretation of Magnetic Resonance Imaging in the Detection of Local Recurrence for Nasopharyngeal Carcinoma: a Randomised Controlled Multicenter Study
Conditions: Artificial Intelligence Supported Image Reviewing Interventions: Diagnostic Test: AI Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Adebrelimab and Chemoradiotherapy in High-risk Locoregionally Advanced Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Nasopharyngeal Cancer Interventions: Drug: Adebrelimab Sponsors: Sun Yat-sen University; Nanfang Hospital, Southern Medical University; West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

Massive Nasal Bleeding in Patients With NPC Received Curative RT
Conditions: Nasopharyngeal Carcinoma Patients Treated With Curative Radiotherapy Interventions: Other: Patients without massive nasal bleeding; Other: Patients with massive nasal bleeding Sponsors: Taichung Veterans General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
Conditions: Metastatic Nasopharyngeal Carcinoma; Intermittent Systematic Chemotherapy Interventions: Drug: Gemcitabine; Drug: Cisplatin; Drug: Paclitaxel protein-bound; Drug: Capecitabine; Drug: Tislelizumab Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma
Conditions: Dysphagia Interventions: Device: Intermittent Oral-esophageal Tube Feeding; Device: Nasogastric Tube Feeding; Behavioral: comprehensive rehabilitation therapy Sponsors: Copka Sonpashan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma Interventions: Radiation: SBRT; Radiation: Low-dose Radiotherapy (LDRT); Drug: Toripalimab; Drug: Gemcitabine; Drug: Cisplatin; Radiation: IMRT Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Herpesvirus 4, Human Interventions: Diagnostic Test: EBV-DNA next generation sequencing Sponsors: Hunan Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Radiotherapy; Complications; IMMUNOTHERAPY Interventions: Radiation: de-escalated radiotherapy; Radiation: conventional radiotherapy Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
Conditions: Nasopharyngeal Carcinoma; Head and Neck Cancer; Radiotherapy-induced Oral Mucositis; Biomarker Sponsors: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials

Effect of Oral Enteral Nutrition in Nasopharyngeal Carcinoma Survivors With Swallowing Disorders
Conditions: Dysphagia Interventions: Device: Nasogastric Tube Feeding; Device: Intermittent Oral-esophageal Tube Feeding; Behavioral: comprehensive rehabilitation therapy Sponsors: Muhammad Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma Interventions: Drug: TPC induction chemotherapy; Drug: GP induction chemotherapy Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Oral Enteral Nutrition in Delayed Onset Radiotherapy-related Swallowing Disorder in Nasopharyngeal Carcinoma
Conditions: Dysphagia Interventions: Device: Intermittent Oral-esophageal Tube Feeding; Device: nasogastric tube feeding Sponsors: Muhammad Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Xerostomia-optimised IMRT Versus Standard IMRT in NPC
Conditions: Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy Interventions: Radiation: Optimised neck CTV; Radiation: standard neck CTV Sponsors: Zhongshan People ' s Hospital, Guangdong, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; High-Risk Cancer; Maintenance Therapy Interventions: Drug: Maintenance Therapy with Toripalimab and Capecitabine; Drug: Maintenance Therapy with Capecitabine Sponsors: Jiangxi Provincial Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials